RxCelerate acquires specialist bioanalytical CRO
UK-headquartered RxCelerate has acquired the specialist bioanalytical contract research organization Total Scientific – increasing its staff to 37 following its expansion stateside in November 2017.
UK-headquartered RxCelerate has acquired the specialist bioanalytical contract research organization Total Scientific – increasing its staff to 37 following its expansion stateside in November 2017.
Syneos Health has launched a Catalyst Ophthalmology Site Network to support startup and delivery of ocular clinical trials.
Charles River has upped to its early discovery capabilities with the addition of high-throughput technologies and expanded pharmacokinetic services.
Johnson & Johnson has reported plans to cut costs across its supply chain as it looks to shifts focus from “older parts” of its portfolio to newer technologies and capabilities, such as in biologics, says CFO.
INTERPHEX 2018
Next-generation regenerative and personalised medicines may be attracting increased industry attention, but small molecule drugs are here to stay, say executives.
Sharp will boost syringe assembly and cold storage capabilities at facilities in the US and the Netherlands.